Ambeed.cn

首页 / 抑制剂/激动剂 / 细胞周期 / PLK / (E/Z)-Rigosertib sodium

(E/Z)-Rigosertib sodium {[allProObj[0].p_purity_real_show]}

货号:A266562 同义名: (E/Z)-ON-01910 sodium;ON-01910 (sodium salt)

Rigosertib Sodium (Random Configuration) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3.

(E/Z)-Rigosertib sodium 化学结构 CAS号:1225497-78-8
(E/Z)-Rigosertib sodium 化学结构
CAS号:1225497-78-8
(E/Z)-Rigosertib sodium 3D分子结构
CAS号:1225497-78-8
(E/Z)-Rigosertib sodium 化学结构 CAS号:1225497-78-8
(E/Z)-Rigosertib sodium 3D分子结构 CAS号:1225497-78-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

(E/Z)-Rigosertib sodium 纯度/质量文件 产品仅供科研

货号:A266562 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >
产品名称 PLK1 PLK2 PLK3 PLK4 其他靶点 纯度
HMN-214 99%+
SBE13 HCl ++++

PLK1, IC50: 200 pM

98%
Onvansertib +++

PLK1, IC50: 2 nM

99%+
Volasertib ++++

PLK1, IC50: 0.87 nM

97%
GSK461364 +++

PLK1, Ki: 2.2 nM

99%+
MLN0905 +++

PLK1, IC50: 2 nM

99%+
Ro3280 ++

PLK1, IC50: 3 nM

99%
(E/Z)-Rigosertib sodium +

PLK1, IC50: 9 nM

+

PLK2, IC50: 260 nM

Bcr-Abl 99%+
BI 2536 ++++

PLK1, IC50: 0.83 nM

++

PLK2, IC50: 3.5 nM

+

PLK3, IC50: 9.0 nM

99%+
CFI-400945 ++

PLK4, IC50: 2.8 nM

Tie-2 98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

(E/Z)-Rigosertib sodium 生物活性

靶点
  • PLK2

    PLK2, IC50:260 nM

  • PLK1

    PLK1, IC50:9 nM

描述 Rigosertib is non-ATP-competitive inhibitor to PLK1 with IC50 of 9 nM. Rigosertib also exhibits inhibition against PLK2, PDGFR, Flt1, BCR-ABL, Fyn, Src, and CDK1, with IC50 of 18-260 nM. Rigosertib shows cell killing activity against 94 different tumor cell lines with IC50 of 50-250 nM, including BT27, MCF-7, DU145, PC3, U87, A549, H187, RF1, HCT15, SW480, and KB cells. While in normal cells, such as HFL, PrEC, HMEC, and HUVEC, Rigosertib has little or no effect unless its concentration is greater than 5-10 μM. In HeLa cells, Rigosertib (100-250 nM) induces spindle abnormalities and apoptosis. Rigosertib also inhibits several multidrug resistant tumor cell lines, including MES-SA, MES-SA/DX5a, CEM, and CEM/C2a, with IC50 of 50-100 nM. In DU145 cells, Rigosertib (0.25-5 μM) blocks cell cycle progression in G2/M phase, results in an accumulation of cells containing subG1 content of DNA, and activates apoptotic pathways. In A549 cells, Rigosertib (50 nM-0.5 μM) induces loss of viability and caspase 3/7 activation. In a recent study, Rigosertib induces apoptosis in chronic lymphocytic leukemia (CLL) cells without toxicity against T-cells or normal B-cells. Rigosertib also abrogates the pro-survival effect of follicular dendritic cells on CLL cells and reduces SDF-1-induced migration of leukemic cells.

(E/Z)-Rigosertib sodium 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
human A2780 cells Proliferation assay 72 h Antiproliferative activity against human A2780 cells assessed as cell growth inhibition after 72 hrs by MTT assay, GI50=62 nM 24471873
human A2780 cells 0.25 μM Function assay 24 h Reduction in Mcl1 level in human A2780 cells at 0.25 uM after 24 hrs by Western blot analysis 24471873
human DU145 cells Proliferation assay 72 h Antiproliferative activity against AR negative human DU145 cells assessed as cell growth inhibition after 72 hrs by MTT assay, GI50=75 nM 24471873
human DU145 cells Cytotoxic assay 96 h Cytotoxicity against human DU145 cells after 96 hrs by trypan blue exclusion assay, IC50=75 nM 21812421

(E/Z)-Rigosertib sodium 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.56mL

2.11mL

1.06mL

21.12mL

4.22mL

2.11mL

(E/Z)-Rigosertib sodium 技术信息

CAS号1225497-78-8
分子式C21H24NNaO8S
分子量 473.472
别名 (E/Z)-ON-01910 sodium;ON-01910 (sodium salt);ON-01910;Rigosertib
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Inert atmosphere,2-8°C

溶解度
动物实验配方

PO 0.5% CMC-Na 40 mg/mL suspension

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。